Remove tag radioligand-therapy
article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

In 2023, there have been pivotal trends shaping the landscape and application of alpha emitter therapy. The discussion centered on the evolving potential of alpha particle therapy for treating advanced and metastatic tumors. Common radionuclides used in alpha therapy include radium-223, actinium-225 and bismuth-213.

DNA 66